Home Op-Ed | Opinion

Op-Ed | Opinion

Op-Ed | Opinion

It’s a Good News-Bad News Kind of Thing…

Editorial Team - November 6, 2020

Doctor discussing treatment options with a patient.

Patient-First Specialty Rx Solutions Expedite Trials, Enhance Compliance and Improve Experience

Easing the Burden of Cancer Beyond Medicine through the Astellas Oncology C3 Prize

Combinability: Addressing Unmet Need in AML

Scientist working in the biosafety cabinet

Why Doctors Don’t Trust Cannabis

Featured Image: Pipette with Cannabis oil. Photo Credit: © 2018 - 2020 Fotolia/Adobe

Providing the Legitimacy of Cannabinoids for the Treatment of Cancer

Guy Chamberland, M.Sc., Ph.D - June 8, 2020

The Value of Biosimilars in the Pandemic Era

Seongwon Han, M.D. - June 5, 2020

Featured Image: Research at Alkermes. Photo Courtesy: © 2020 Alkermes, Inc.

Re-Engineering Molecules to Drive Innovation in Cancer Immunotherapy

Heather Losey, Ph.D. - June 1, 2020

The Road to Recovery Must Include Communities of Color

Maya Rockeymoore Cummings, MA, Ph.D. - May 25, 2020

Managing the Viral Scourge – How to Find Hope and Face...

Peter Hofland, Ph.D - March 19, 2020

Three Necessary Pillars to Revolutionize Clinical Trial Design

Andrea Wilson Woods - March 6, 2020

Doctor discussing treatment options with a patient.

Want to Improve Patient Relationships? Let Them Express Their Preferences

Jeff Jarvis - March 5, 2020

Physician consulting with a patients in hospital exam room.

The Emotional and Psychological Struggle of Being a Doctor

Shannon Sovndal, MD - February 21, 2020

The Nuts & Bolts of High Intensity Focal Ultrasound

John Russell Valvo, MD - January 10, 2020

Celebrate Being a Holiday Hero—How to Build Your Resilience Despite Working...

Gary R. Simonds, MD, MHCDS - December 23, 2019

12 3 4 Page 1 of 4

LATEST NEWS

Dexamethasone Decreases the Efficacy of Immune Checkpoint Inhibitors in Patients With Glioblastoma

Editorial Team - November 27, 2020

Europe Validates Application for Tepotinib for Advanced NSCLC with METex14 Skipping Alterations

Peter Hofland, Ph.D - November 26, 2020

U.S. FDA Approves Naxitamab for the Treatment of Neuroblastoma

Peter Hofland, Ph.D - November 26, 2020

EMA Recommends Approval of Tagraxofusp for Blastic Plasmacytoid Dendritic Cell Neoplasm

Editorial Team - November 24, 2020

Social Needs Linked to Low Health-Related Quality of Life Among African American Cancer Survivors

Editorial Team - November 23, 2020

Press Releases | Cancer

Mental Health Startup, Taliaz, Inks Partnership Agreement with... December 2, 2020
The agreement will accelerate commercialization of its AI mental health platform, PREDICTIX, in Australia, New Zealand and the USA, pending regulatory approval.(PRWeb December 02, 2020)Read the full story at https://www.prweb.com/releases/mental_health_startup_taliaz_inks_partnership_agreement_with_molecular_diagnostics_leader_genetic_technologies/prweb17580983.htm
Karmanos Cancer Institute to implement OncoLens virtual tumor board... December 1, 2020
Greater collaboration on a secure digital platform across 16 locations will improve continuum of care for patients(PRWeb December 01, 2020)Read the full story at https://www.prweb.com/releases/karmanos_cancer_institute_to_implement_oncolens_virtual_tumor_board_and_cancer_treatment_planning_software_solutions/prweb17578712.htm
BoniMedics partners with scar treatment pioneer, Biodermis® to... November 30, 2020
BoniMedics is bringing Biodermis' proven line of silicone scar treatment products to Sweden, Denmark, Norway and Finland(PRWeb November 30, 2020)Read the full story at https://www.prweb.com/releases/bonimedics_partners_with_scar_treatment_pioneer_biodermis_to_bring_patented_pro_sil_to_northern_europe/prweb17558605.htm